Insider Transactions in Q1 2024 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
John Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
215,600
+22.3%
|
$215,600
$1.99 P/Share
|
|
Mar 15
2024
|
Jeffrey W Sherman Director |
BUY
Other acquisition or disposition
|
Direct |
6,502
+5.38%
|
-
|
|
Mar 15
2024
|
Garheng Kong Director |
BUY
Other acquisition or disposition
|
Direct |
6,474
+5.37%
|
-
|
|
Mar 15
2024
|
John Johnson Director |
BUY
Other acquisition or disposition
|
Direct |
89,571
+9.63%
|
-
|
|
Mar 14
2024
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
4,500
+29.03%
|
$9,000
$2.16 P/Share
|
|
Jan 31
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
110,750
-7.16%
|
$221,500
$2.46 P/Share
|
|
Jan 31
2024
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,131
-3.9%
|
$30,262
$2.46 P/Share
|
|
Jan 31
2024
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,909
-3.22%
|
$91,818
$2.46 P/Share
|
|
Jan 31
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
110,750
-4.9%
|
$221,500
$2.46 P/Share
|
|
Jan 31
2024
|
Beth Hecht Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+32.54%
|
-
|
|
Jan 31
2024
|
Kenneth Erland Johnson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+28.14%
|
-
|
|
Jan 31
2024
|
John Patrick Shannon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+25.79%
|
-
|
|
Jan 31
2024
|
Steven Pieper Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+21.67%
|
-
|
|
Jan 31
2024
|
Paul R Edick Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+28.37%
|
-
|
|
Jan 29
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-0.28%
|
$8,758
$2.66 P/Share
|
|
Jan 29
2024
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,747
-2.69%
|
$21,494
$2.66 P/Share
|
|
Jan 29
2024
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,675
-1.36%
|
$39,350
$2.66 P/Share
|
|
Jan 29
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
22,150
-0.97%
|
$44,300
$2.66 P/Share
|
|
Jan 03
2024
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,067
-1.46%
|
$46,134
$2.24 P/Share
|
|
Jan 03
2024
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,400
-3.01%
|
$24,800
$2.24 P/Share
|
|
Jan 03
2024
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,488
-2.26%
|
$66,976
$2.24 P/Share
|
|
Jan 03
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
40,834
-1.76%
|
$81,668
$2.24 P/Share
|